The autoantibody repertoire: searching for order

The spontaneously occurring autoantibodies that are associated with human diseases bear the hallmarks of a typical immune response. The repertoire of autoantibodies is surprisingly limited, however, and is the same in both humans and mice. Neither molecular mimicry nor immune dysregulation accounts for this unexpectedly narrow focus of specificities. Experimental data on the properties of the target autoantigens — such as their structure, catabolism, exposure to the immune system after cell death and recently described immunostimulatory effects on immature dendritic cells — indicate that these properties, in conjunction with the tissue microenvironment, help to select the autoantibody repertoire.

[1]  K. Bachmaier Regulation of autoimmunity by the molecular adaptor Cbl-b , 2000 .

[2]  A. Rosen,et al.  Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status , 1999, The Journal of experimental medicine.

[3]  David C. H. Yang,et al.  Histidyl–tRNA Synthetase and Asparaginyl–tRNA Synthetase, Autoantigens in Myositis, Activate Chemokine Receptors on T Lymphocytes and Immature Dendritic Cells , 2002, The Journal of experimental medicine.

[4]  S Karlin,et al.  Very long charge runs in systemic lupus erythematosus-associated autoantigens. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Martinis,et al.  Aminoacyl-tRNA synthetases: a new image for a classical family. , 1999, Biochimie.

[6]  K. Wucherpfennig Structural basis of molecular mimicry. , 2001, Journal of autoimmunity.

[7]  I. Maclennan,et al.  Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. , 2002, Immunity.

[8]  Stefania Gallucci,et al.  Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.

[9]  P. Matzinger The Danger Model: A Renewed Sense of Self , 2002, Science.

[10]  S. Gershoff,et al.  Studies on synthetic polypeptide antigens. XX. Genetic control of the antibody response in the rat to structurally different synthetic polypeptide antigens. , 1968, Journal of immunology.

[11]  D. Papermaster,et al.  Studies on synthetic polypeptide antigens. 18. The role of composition, charge, and optical isomerism in the immunogenicity of synthetic polypeptides. , 1967, Journal of Biological Chemistry.

[12]  Tak W. Mak,et al.  Knockout mice: a paradigm shift in modern immunology , 2001, Nature Reviews Immunology.

[13]  G. Pruijn,et al.  The fate of U1 snRNP during anti-Fas induced apoptosis: specific cleavage of the U1 snRNA molecule , 2000, Cell Death and Differentiation.

[14]  V. Fadok,et al.  Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. , 2002, The Journal of clinical investigation.

[15]  N. Raben,et al.  A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope. , 1994, The Journal of biological chemistry.

[16]  R. Scott,et al.  Phagocytosis and clearance of apoptotic cells is mediated by MER , 2001, Nature.

[17]  A. Rolink,et al.  BAFFled B cells survive and thrive: roles of BAFF in B-cell development. , 2002, Current opinion in immunology.

[18]  M. Madaio,et al.  The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice. , 1999, Journal of immunology.

[19]  P. Anderson,et al.  Death, autoantigen modifications, and tolerance , 2000, Arthritis research.

[20]  M. Satoh,et al.  Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane , 2000, Clinical and experimental immunology.

[21]  G. Pruijn,et al.  The La (SS-B) autoantigen, a key protein in RNA biogenesis, is dephosphorylated and cleaved early during apoptosis , 1999, Cell Death and Differentiation.

[22]  P. Taylor,et al.  A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo , 2000, The Journal of experimental medicine.

[23]  J. Minna,et al.  Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. , 1992, Cancer research.

[24]  F. Miller,et al.  The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Pisetsky,et al.  Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation , 1990, The Journal of experimental medicine.

[26]  K. Wucherpfennig,et al.  Mechanisms for the induction of autoimmunity by infectious agents. , 2001, The Journal of clinical investigation.

[27]  M. Mathews,et al.  Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity , 1983, Nature.

[28]  P. Lipsky Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity , 2001, Nature Immunology.

[29]  R. Wada,et al.  Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Rosen,et al.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.

[31]  J. Ahearn,et al.  Novel packages of viral and self-antigens are generated during apoptosis , 1995, The Journal of experimental medicine.

[32]  Nina Bhardwaj,et al.  Consequences of cell death: exposure to necrotic tumor cells , 2000 .

[33]  S. Stacker,et al.  Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease , 1995, Cell.

[34]  A. Lupas,et al.  Long charge-rich alpha-helices in systemic autoantigens. , 1993, Biochemical and Biophysical Research Communications - BBRC.

[35]  E. Sercarz,et al.  Self-reactive T cells and degeneracy of T cell recognition: evolving concepts-from sequence homology to shape mimicry and TCR flexibility. , 2001, Journal of autoimmunity.

[36]  P H Plotz,et al.  The role of autoantibodies in autoimmune disease. , 1993, Annual review of immunology.

[37]  J. Tschopp,et al.  Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations , 1999, The Journal of experimental medicine.

[38]  T. Möröy,et al.  Features of systemic lupus erythematosus in Dnase1-deficient mice , 2000, Nature Genetics.

[39]  M. Shlomchik,et al.  Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.

[40]  R. Doms,et al.  Diversity of receptors binding HIV on dendritic cell subsets , 2002, Nature Immunology.

[41]  Å. Lernmark,et al.  Autoimmune diseases: are markers ready for prediction? , 2001, The Journal of clinical investigation.

[42]  B. Nardelli,et al.  DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL , 2002, Nature Immunology.

[43]  E. Wakeland,et al.  The genetics of complex autoimmune diseases: non-MHC susceptibility genes , 2001, Nature Immunology.

[44]  A. Sher,et al.  Positive and negative regulation of pathogen induced dendritic cell function by G-protein coupled receptors. , 2002, Molecular immunology.

[45]  J. Zunt,et al.  Autoimmunity due to molecular mimicry as a cause of neurological disease , 2002, Nature Medicine.

[46]  P. Anderson,et al.  The 72-kDa Component of Signal Recognition Particle Is Cleaved during Apoptosis* , 1998, The Journal of Biological Chemistry.

[47]  P. Schimmel,et al.  Two distinct cytokines released from a human aminoacyl-tRNA synthetase. , 1999, Science.

[48]  Åke Lernmark,et al.  Series Introduction: Autoimmune diseases: are markers ready for prediction? , 2001 .

[49]  Charles A. Janeway,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:How the immune system works to protect the host from infection: A personal view , 2001 .

[50]  J. Rodríguez-Sánchez,et al.  Autoantibodies to a transfer RNA-associated protein in a murine model of chronic graft versus host disease. , 1994, Journal of immunology.